Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia

by Tali Azenkot, Brian A. Jonas
Published 2022-07-01

Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations wi...

by Brian A Jonas, Carl Johnson, Dita Gratzinger, Ravindra Majeti
Published 2016-01-01

Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia

by Jacob D. Kjelland, Denis M. Dwyre, Brian A. Jonas
Published 2017-01-01

Proteinuria, Hypoalbuminemia, and Chronic Lymphocytic Leukemia: An Unusual Trio

by William Wung MD, Shubha Ananthakrishnan MD, Brian A. Jonas MD
Published 2018-03-01

A phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML

by Brian A. Jonas, Laura A. Potter, Maria Galkin, Joseph M. Tuscano
Published 2023-01-01

Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center

by Matthew E. Tenold, Benjamin N. Moskoff, David J. Benjamin, Rasmus T. Hoeg, Aaron S. Rosenberg, Mehrdad Abedi, Joseph M. Tuscano, Joseph M. Tuscano, Brian A. Jonas, Brian A. Jonas
Published 2021-03-01

Acute Myeloid Leukemia with Isolated Trisomy 19 Associated with Diffuse Myelofibrosis and Osteosclerosis

by Adam Stelling, Brian A. Jonas, Hooman H. Rashidi, Mehrdad Abedi, Mingyi Chen
Published 2015-12-01

Prolonged Response of a Patient with Relapsed Acute Myeloid Leukemia to a Novel Oral Bromodomain Extraterminal Inhibitor (BETi)

by Meilen Chang Muñoz, Jennifer A. Murphy, Johannes E. Wolff, Brian A. Jonas
Published 2020-01-01

Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: A novel variant of myeloid proliferative neoplasm with eosinophilia

by Ruijun Jeanna Su, Brian A. Jonas, Jeanna Welborn, Jeffrey Paul Gregg, Mingyi Chen
Published 2016-09-01

P555: OLUTASIDENIB IN POST-VENETOCLAX PATIENTS WITH MUTANT IDH1 AML

by Jorge Cortes, Justin M. Watts, Gary Schiller, Leslie Todd, Aaron Sheppard, Brian A. Jonas
Published 2023-08-01

Optimal Molecular Methods in Detecting p190BCR-ABL Fusion Variants in Hematologic Malignancies: A Case Report and Review of the Literature

by Rebecca J. Sonu, Brian A. Jonas, Denis M. Dwyre, Jeffrey P. Gregg, Hooman H. Rashidi
Published 2015-01-01

Translocation (6;15)(q12;q15): A Novel Mutation in a Patient with Therapy-Related Myelodysplastic Syndrome

by Saba F. Ali, Rebecca J. Sonu, Denis M. Dwyre, Brian A. Jonas, Hooman H. Rashidi
Published 2015-01-01

S310: VENETOCLAX PLUS AZACITIDINE DELAYS DETERIORATION OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: VIALE-A LONG-TERM FOLLOW UP

by Keith Pratz, Catherine Lai, Brian A. Jonas, Courtney Dinardo, Cat N. Bui, Rajesh Kamalakar, Jalaja Potluri, Wei-Han Chang, Rohini Sen, Thomas W Leblanc
Published 2023-08-01

Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science

by Michael A. Malfatti, Bruce A. Buchholz, Heather A. Enright, Benjamin J. Stewart, Ted J. Ognibene, A. Daniel McCartt, Gabriela G. Loots, Maike Zimmermann, Tiffany M. Scharadin, George D. Cimino, Brian A. Jonas, Chong-Xian Pan, Graham Bench, Paul T. Henderson, Kenneth W. Turteltaub
Published 2019-05-01

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia

by Keith W. Pratz, Panayiotis Panayiotidis, Christian Recher, Xudong Wei, Brian A. Jonas, Pau Montesinos, Vladimir Ivanov, Andre C. Schuh, Courtney D. DiNardo, Jan Novak, Vlatko Pejsa, Don Stevens, Su-Peng Yeh, Inho Kim, Mehmet Turgut, Nicola Fracchiolla, Kazuhito Yamamoto, Yishai Ofran, Andrew H. Wei, Cat N. Bui, Katy Benjamin, Rajesh Kamalakar, Jalaja Potluri, Wellington Mendes, Jacob Devine, Walter Fiedler
Published 2022-04-01